$RNVA reversal for real ok
Par value 01
Par value mandate states any issuance below par holds shareholder liable for the difference between issue price and face value aka par, selling under 01 has not been dilution, but abusive shorts via NITE. Major squeeze commencing
Rennova Health, Inc. (Rennova), formerly CollabRx, Inc., is a provider of health care services to healthcare providers, patients and individuals. The Company operates in two segments: Clinical Laboratory operations, and Hospital operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers. Rennova's principal line of business is clinical laboratory blood and urine testing services. It is also engaged in the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities in the United States. Its clinical laboratories include Biohealth Medical Laboratory, Inc.; Alethea Laboratories, Inc.; International Technologies, LLC; EPIC Reference Labs, Inc., and Epinex Diagnostics Laboratories, Inc.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
